Patent · US Active

Pyrimidine FGFR4 inhibitors

US10537571B2 · kind B2 · utility

0Cited by
5References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 2017
Grant dateJan 21, 2020
Priority date—
Expiry dateJun 20, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds of Formula I useful as FGFR4 inhibitors, as well as methods of use of the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.